An old drug with new tricks; examining the anti-cancer potential of metformin in mouse and cell models of EML4-ALK+ non-small cell lung cancer AR Bland University of Otago, 2021 | | 2021 |
Considerations for Whole-Slide Analysis of Murine Xenografts Experiments AR Bland, JC Ashton Journal of Histochemistry & Cytochemistry 69 (10), 627-631, 2021 | | 2021 |
Curcumin: A small molecule with big functionality against amyloid aggregation in neurodegenerative diseases and type 2 diabetes S Radbakhsh, GE Barreto, AR Bland, A Sahebkar Biofactors 47 (4), 570-586, 2021 | 29 | 2021 |
Curcumin: an inflammasome silencer S Hasanzadeh, MI Read, AR Bland, M Majeed, T Jamialahmadi, ... Pharmacological research 159, 104921, 2020 | 228 | 2020 |
Cytotoxicity of curcumin derivatives in ALK positive non-small cell lung cancer AR Bland, RL Bower, M Nimick, BC Hawkins, RJ Rosengren, JC Ashton European journal of pharmacology 865, 172749, 2019 | 12 | 2019 |
Does crizotinib auto-inhibit CYP3A in vivo? AR Bland, N Shrestha, RJ Rosengren, JC Ashton Pharmacology 105 (11-12), 715-718, 2020 | 5 | 2020 |
Does the mouse tail vein injection method provide a good model N Shrestha, Z Lateef, O Martey, AR Bland, M Nimick, R Rosengren, ... cancer, 190, 2019 | | 2019 |
Does the mouse tail vein injection method provide a good model of lung cancer? N Shrestha, Z Lateef, O Martey, AR Bland, M Nimick, R Rosengren, ... F1000Research 8, 2019 | 9 | 2019 |
EP02. 01-01 Differing Cell Cycle Responses for Alectinib and SHP099 in Variant 1 and Variant 3 ALK+ Non-Small Cell Lung Cancer Cell Lines M Berry, A Bland, J Ashton Journal of Thoracic Oncology 18 (11), S424-S425, 2023 | | 2023 |
Experimental determination of cancer drug targets with independent mechanisms of resistance AR Bland, N Shrestha, M Berry, C Wilson, JC Ashton Current cancer drug targets 22 (2), 97-107, 2022 | 1 | 2022 |
Inflammasomes and colorectal cancer SK Shahbaz, K Koushki, SHA Ayati, AR Bland, EE Bezsonov, A Sahebkar Cells 10 (2172), 2021 | 25 | 2021 |
Inhibition of Mitogen-Activated Protein Kinase Kinase Alone and in Combination with Anaplastic Lymphoma Kinase (ALK) Inhibition Suppresses Tumor Growth in a Mouse Model of ALK … N Shrestha, AR Bland, RL Bower, RJ Rosengren, JC Ashton Journal of Pharmacology and Experimental Therapeutics 374 (1), 134-140, 2020 | 3 | 2020 |
Is Brca-Associated Protein (Bap1) A New Drug Target to Combat Metastatic Uveal Melanoma? AR Bland, RJ Rosengren Open Access Journal of Toxicology 3 (4), 2018 | | 2018 |
Mechanisms of synergistic suppression of ALK-positive lung cancer cell growth by the combination of ALK and SHP2 inhibitors MA Berry, AR Bland, JC Ashton Scientific Reports 13 (1), 10041, 2023 | 2 | 2023 |
P1. 01-05 Metformin in Combination with Crizotinib for The Treatment of EML4-ALK+ Lung Cancer A Bland, M Nimick, J Ashton Journal of Thoracic Oncology 13 (10), S460-S461, 2018 | | 2018 |
P2. 14-66 Combination ALK and MEK Inhibition in ALK-Positive Lung Cancer J Ashton, N Shrestha, A Bland Journal of Thoracic Oncology 14 (10), S857, 2019 | 1 | 2019 |
Proceedings of the 238th Otago Medical School Research Society Meeting-Summer Student Speaker Awards; 10 May 2017 JT Thomas, EV Todd, H Liu, MS Lamm, K Rutherford, JR Godwin, ... 238th Otago Medical School Research Society Meeting-Summer Student Speaker …, 2017 | | 2017 |
Proceedings of the 242nd Otago Medical School Research Society Meeting-Masters/Honours Student Speaker Awards; 1 Nov 2017 ML Scott, TT Cheung, KL Hamilton, FJ McDonald, J Drew, A Macmillan, ... 242nd Otago Medical School Research Society Meeting-Masters/Honours Student …, 2018 | | 2018 |
Proceedings of the 251st Otago Medical School Research Society Meeting-PhD Student Speaker Awards; 9 Oct 2019 S Sethi, RA Augustine, GT Bouwer, DO Schwenke, CH Brown, ... 251st Otago Medical School Research Society Meeting-PhD Student Speaker Awards, 2020 | | 2020 |
Repurposing the hypoglycemic agent, metformin, for targeted lung cancer AR Bland, N Shrestha, RL Bower, RJ Rosengren, JC Ashton 255th Otago Medical School Research Society Meeting-PhD Student Speaker Awards, 2021 | | 2021 |